Taconic Capital Advisors’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-206,000
Closed -$2.06M 685
2022
Q3
$2.06M Hold
206,000
0.05% 312
2022
Q2
$2.04M Buy
+206,000
New +$2.03M 0.05% 318

Taconic Capital Advisors's LUXA Position: Q4 2022 in Review

Taconic Capital Advisors sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 206,000 shares — an estimated $2.06M sold.

Taconic Capital Advisors first reported a position in LUXA in Q2 2022 and held it in 2 quarters. The position peaked at $2.06M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Taconic Capital Advisors reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Taconic Capital Advisors sold 206,000 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.06M.
  • Taconic Capital Advisors first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Taconic Capital Advisors's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.06M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Taconic Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.